Merck & Co., Inc. (MRK) is a Healthcare stock trading at $114.02 (as of 2026-06-18), with a market capitalization of $293.22B and a trailing P/E of 33.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Merck & Co., Inc. is a global healthcare company organized into the Pharmaceutical and Animal Health segments. It develops and markets human pharmaceutical products and vaccines, and veterinary medicines, vaccines, and health management and identification/traceability offerings, serving wholesalers and retailers, healthcare providers and institutions, and veterinarians and animal producers.